Related references
Note: Only part of the references are listed.Cardiac Safety of Kinase Inhibitors - Improving Understanding and Prediction of Liabilities in Drug Discovery Using Human Stem Cell-Derived Models
Ricarda Ziegler et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis
Hagop M. Kantarjian et al.
LEUKEMIA (2021)
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
Michael Frisk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Paul M. Ridker et al.
CIRCULATION RESEARCH (2021)
Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma
Bei Zhou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Cardiotoxicity of sorafenib is mediated through elevation of ROS level and CaMKII activity and dysregulation of calcium homoeostasis
Wenzhuo Ma et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)
ATF6 as a Nodal Regulator of Proteostasis in the Heart
Christopher C. Glembotski et al.
FRONTIERS IN PHYSIOLOGY (2020)
Ponatinib-induced ischemic stroke in larval zebrafish for drug screening
Xiao-Yu Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial
Li Xuan et al.
LANCET ONCOLOGY (2020)
Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicity
J. G. Coen van Hasselt et al.
NATURE COMMUNICATIONS (2020)
Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia
Onyee Chan et al.
BLOOD ADVANCES (2020)
Development of a sandwich enzyme-linked immunosorbent assay for the quantification of ponatinib in serum
Yuta Yamamoto et al.
ANALYTICAL BIOCHEMISTRY (2019)
Adaptation of Human iPSC-Derived Cardiomyocytes to Tyrosine Kinase Inhibitors Reduces Acute Cardiotoxicity via Metabolic Reprogramming
Huan Wang et al.
CELL SYSTEMS (2019)
ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb
Erik A. Blackwood et al.
CIRCULATION RESEARCH (2019)
Nrf2/HO-1 Mediated Protective Activity of Genistein Against Doxorubicin-Induced Cardiac Toxicity
Miao Chen et al.
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2019)
Melatonin Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib through the PERK-ATF4-Beclin1 Pathway
Bei Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial
Jorge E. Cortes et al.
BLOOD (2018)
Crizotinib-induced simultaneous multiple cardiac toxicities
Takuya Oyakawa et al.
INVESTIGATIONAL NEW DRUGS (2018)
ROS signaling and ER stress in cardiovascular disease
Cristhiaan D. Ochoa et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
Chaoyang Ye et al.
NATURE COMMUNICATIONS (2018)
Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation
Jesus Paez-Mayorga et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
ATF6 Decreases Myocardial Ischemia/Reperfusion Damage and Links ER Stress and Oxidative Stress Signaling Pathways in the Heart
Jung-Kang Jin et al.
CIRCULATION RESEARCH (2017)
Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response
Conggang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
Arun Sharma et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naive Chronic Myeloid Leukemia Patients Trial
Jorge E. Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
A. Hochhaus et al.
LEUKEMIA (2016)
Biology of the cardiac myocyte in heart disease
Angela K. Peter et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Nilotinib Induces ER Stress and Cell Death in H9c2 Cells
D. Lekes et al.
PHYSIOLOGICAL RESEARCH (2016)
The unfolded protein response in immunity and inflammation
Joep Grootjans et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
Naomi B. Haas et al.
CLINICAL CANCER RESEARCH (2015)
Crizotinib-induced cardiotoxicity: the importance of a proactive monitoring and management
Alfredo Tartarone et al.
FUTURE ONCOLOGY (2015)
Endoplasmic Reticulum Stress Activates the Inflammasome via NLRP3-and Caspase-2-Driven Mitochondrial Damage
Denise N. Bronner et al.
IMMUNITY (2015)
Spliced X-Box Binding Protein 1 Couples the Unfolded Protein Response to Hexosamine Biosynthetic Pathway
Zhao V. Wang et al.
CELL (2014)
Activating Transcription Factor 4 Links Metabolic Stress to Interleukin-6 Expression in Macrophages
Yorihiro Iwasaki et al.
DIABETES (2014)
Endoplasmic Reticulum Stress Sensor Protein Kinase R-Like Endoplasmic Reticulum Kinase (PERK) Protects Against Pressure Overload-Induced Heart Failure and Lung Remodeling
Xiaoyu Liu et al.
HYPERTENSION (2014)
Quantitative single-cell RNA-seq with unique molecular identifiers
Saiful Islam et al.
NATURE METHODS (2014)
Heart rate decrease during crizotinib treatment and potential correlation to clinical response
Sai-Hong Ignatius Ou et al.
CANCER (2013)
Stress-Independent Activation of XBP1s and/or ATF6 Reveals Three Functionally Diverse ER Proteostasis Environments
Matthew D. Shoulders et al.
CELL REPORTS (2013)
Clinical cardiac safety profile of nilotinib
Theo D. Kim et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
Claudio Hetz
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis
Ying-Hong Shi et al.
AUTOPHAGY (2011)
Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib
Christopher J. Richards et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation
Gary Gintant
PHARMACOLOGY & THERAPEUTICS (2011)
Ablation of C/EBP Homologous Protein Attenuates Endoplasmic Reticulum-Mediated Apoptosis and Cardiac Dysfunction Induced by Pressure Overload
Hai Ying Fu et al.
CIRCULATION (2010)
Clinical Pharmacokinetics of the BCR-ABL Tyrosine Kinase Inhibitor Nilotinib
C. Tanaka et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Differences in Effects on Myocardium and Mitochondria by Angiogenic Inhibitors Suggest Separate Mechanisms of Cardiotoxicity
Kevin J. French et al.
TOXICOLOGIC PATHOLOGY (2010)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells
Yvonne Will et al.
TOXICOLOGICAL SCIENCES (2008)
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu et al.
LANCET (2007)
The kinase inhibitor sorafenib induces cell death through a process involving induction of endoplasmic reticulum stress
Mohamed Rahmani et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkela et al.
NATURE MEDICINE (2006)
TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death
N Ohoka et al.
EMBO JOURNAL (2005)
Hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria
T Gotoh et al.
CELL DEATH AND DIFFERENTIATION (2004)
Activation signal of nuclear factor-κB in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2
M Kaneko et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2003)
ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats
H Nishitoh et al.
GENES & DEVELOPMENT (2002)
Share Paper
